Posted in | News | Petrochemicals

Sabic Sign Letters of Intent for Construction of New Plant

SABIC affiliate, Eastern Petrochemical Company (SHARQ), has signed letters of intent to award contracts to:

1.Stone & Webster Ltd., UK, to construct an Olefins Plant with a production capacity of 1,300,000 MT per annum of Ethylene;

2.Samsung Engineering Company Ltd., South Korea, to construct its Ethylene Glycol Plant with a production capacity of 700,000 MT per annum (increasing overall Ethylene Glycol production capacity to more than 2,000,000 MT per annum).

3.Linde, Germany, to construct its Linear Low and High Density Polyethylene plants with a production capacity of 800,000 MT per annum, which will increase polyolefins production at SHARQ to reach more than 1,600,000 MT per annum.

Mohamed Al-Mady, SABIC Vice Chairman and CEO said, “SHARQ’s expansion project will add 2.8m MT annually to SABIC’s production and will further enhance SHARQ’s position as the world’s largest single producer of Ethylene Glycol. This will also enhance SABIC’s global ranking alongside the other global petrochemicals companies who produce this product. SABIC is currently ranked 2nd and is expected to become number one once this project comes on stream. SABIC is the world’s 3rd largest producer of polyethylene and number four for polyolefins.”

The agreements will cover engineering, procurement and construction of the plants at the SHARQ affiliate in Al-Jubail, Saudi Arabia. These will be complete by the first quarter of 2008.

The letters of intent were signed by Mr. Mohammad Al-Jabri, SHARQ President, with executive representatives from Stone Webster Ltd., Samsung Engineering Company and Linde.

SHARQ is a joint venture equally owned by Saudi Basic Industries Corporation (SABIC) and SPDC Ltd, a Japanese consortium led by the government of Japan and the Mitsubishi group of companies.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.